James G Barbee

Summary

Affiliation: Louisiana State University Health Sciences Center
Country: USA

Publications

  1. ncbi The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans 70112, USA
    J Clin Psychiatry 65:975-81. 2004
  2. ncbi Lamotrigine as an augmentation agent in treatment-resistant depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, 1542 Tulane Ave, Box T4 6, New Orleans, LA 70122, USA
    J Clin Psychiatry 63:737-41. 2002
  3. ncbi Aripiprazole augmentation in treatment-resistant depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Ann Clin Psychiatry 16:189-94. 2004
  4. ncbi A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Medical Center, 1542 Tulane Avenue, New Orleans, LA 70112, USA
    J Affect Disord 73:229-36. 2003
  5. ncbi Topiramate in the treatment of severe bulimia nervosa with comorbid mood disorders: a case series
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Int J Eat Disord 33:468-72. 2003
  6. doi A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, LA, USA
    J Clin Psychiatry 72:1405-12. 2011
  7. ncbi Stability of worry content in GAD patients: a descriptive study
    Joseph I Constans
    Department of Psychiatry, Louisiana State University School of Medicine, New Orleans, USA
    J Anxiety Disord 16:311-9. 2002
  8. ncbi Mental health and recovery in the Gulf Coast after Hurricanes Katrina and Rita
    Richard H Weisler
    Department of Psychiatry, University of North Carolina at Chapel Hill, and Duke University Medical Center, Durham 27609, USA
    JAMA 296:585-8. 2006

Detail Information

Publications8

  1. ncbi The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans 70112, USA
    J Clin Psychiatry 65:975-81. 2004
    ..To date, there have been no reports in the literature regarding the effectiveness of these drugs when trials of one or more of them have failed previously as antidepressant augmentation...
  2. ncbi Lamotrigine as an augmentation agent in treatment-resistant depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, 1542 Tulane Ave, Box T4 6, New Orleans, LA 70122, USA
    J Clin Psychiatry 63:737-41. 2002
    ..However, there is a paucity of research on the use of lamotrigine as an augmentation agent in treatment-refractory unipolar major depressive disorder...
  3. ncbi Aripiprazole augmentation in treatment-resistant depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Ann Clin Psychiatry 16:189-94. 2004
    ..The authors hypothesized that aripiprazole would be efficacious in augmenting antidepressant treatment in resistant patients with non-psychotic unipolar depression who had previously failed a trial of another atypical neuroleptic...
  4. ncbi A follow-up study of DSM-III-R generalized anxiety disorder with syndromal and subsyndromal major depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Medical Center, 1542 Tulane Avenue, New Orleans, LA 70112, USA
    J Affect Disord 73:229-36. 2003
    ..The authors examined the long-term outcome of generalized anxiety disorder with depressive symptoms utilizing both categorical and dimensional analyses...
  5. ncbi Topiramate in the treatment of severe bulimia nervosa with comorbid mood disorders: a case series
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112, USA
    Int J Eat Disord 33:468-72. 2003
    ..To report observations on the efficacy and tolerability of topiramate in a sample of five patients with severe symptoms of bulimia nervosa and comorbid mood and/or anxiety disorders...
  6. doi A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression
    James G Barbee
    Department of Psychiatry, Louisiana State University Health Sciences Center, New Orleans, LA, USA
    J Clin Psychiatry 72:1405-12. 2011
    ..This study is the largest double-blind placebo-controlled study conducted to date of lamotrigine in this role...
  7. ncbi Stability of worry content in GAD patients: a descriptive study
    Joseph I Constans
    Department of Psychiatry, Louisiana State University School of Medicine, New Orleans, USA
    J Anxiety Disord 16:311-9. 2002
    ..Most participants did identify new worry topics during the course of the 12-month period, and the frequency and intensity of the new worries were comparable to the decrease in frequency and intensity of the original worries...
  8. ncbi Mental health and recovery in the Gulf Coast after Hurricanes Katrina and Rita
    Richard H Weisler
    Department of Psychiatry, University of North Carolina at Chapel Hill, and Duke University Medical Center, Durham 27609, USA
    JAMA 296:585-8. 2006